Methods and apparatus for nucleic acid sequencing by signal stretching and data integration

• US 8,574,892 B2
• Filed: 09/22/2005
• Issued: 11/05/2013
• Est. Priority Date: 06/17/2002
• Status: Active Grant

• Current Assignee: Intel Corporation
• Original Assignee: Intel Corporation
• Inventors: Su, Xing
• Primary Examiner(s): Bhat, Narayan
• Application Number:
  US11/233,933
• Publication Number:
  US 20070231795A1
• Time in Patent Office: 2,966 Days
• Field of Search: 435/6.1, 435/6.11, 435/6.12, 435/283.1, 435/287.2, 536/23.1, 536/24.3, 536/24.33, 700/20, 977/700, 977/704, 977/719, 977/924
• US Class Current: 435/287.2
• CPC Class Codes: B82Y 5/00 Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
• CPC Class Codes: C12Q 1/6869 Methods for sequencing
• CPC Class Codes: C12Q 2565/631 being a biochannel or pore
• CPC Class Codes: Y10S 977/853 Biological sample

Abstract

The methods and apparatus 100 disclosed herein concern DNA sequencing. In some embodiments of the invention, the methods comprise measuring the distance between labeled nucleotides 220, such as nucleotides labeled with bulky groups. The methods may further comprise placing identical template DNA 200 into four reaction chambers 110, 120, 130, 140, each containing a different labeled nucleotide precursor, synthesizing complementary strands 230, 240, 250 and detecting labeled nucleotides 220. The distances between labeled nucleotides 220 may be used to construct 450 distance maps 310, 320, 330, 340 for each type of labeled nucleotide 220. The distance maps 310, 320, 330, 340 may be aligned 520 to obtain a nucleic acid sequence 210. Overlapping data analysis and frequency analysis may be used to construct 450 the distance maps 310, 320, 330, 340 and non-overlapping data analysis may be used to align 520 the distance maps into a sequence 210.

Claims

1. The nucleic acid sequencing apparatus comprising:

a first reaction chamber comprising non-labeled nucleotide precursors and only a single type of labeled nucleotide precursor being a first labeled nucleotide precursor, the first labeled nucleotide precursor consisting of labeled deoxyadenosine-5′

-triphosphate (dATP), a copy of a template nucleic acid, a synthetic reagent and a primer, the first reaction chamber configured to synthesize a first labeled nucleic acid strand comprising the first labeled nucleotide precursor and complementary to the template nucleic acid;

a second reaction chamber comprising non-labeled nucleotide precursors and only a single type of labeled nucleotide precursor being a second labeled nucleotide precursor, the second labeled nucleotide precursor consisting of labeled deoxycytosine-5′

-triphosphate (dCTP), a copy of the template nucleic acid, a synthetic reagent and a primer, the second reaction chamber configured to synthesize a second labeled nucleic acid strand comprising the second labeled nucleotide precursor and complementary to the template nucleic acid;

a third reaction chamber comprising non-labeled nucleotide precursors and only a single type of labeled nucleotide precursor being a third labeled nucleotide precursor, the third labeled nucleotide precursor consisting of labeled deoxythymidine-5′

-triphosphate (dTTP), a copy of the template nucleic acid, a synthetic reagent and a primer, the third reaction chamber configured to synthesize a third labeled nucleic acid strand comprising the third labeled nucleotide precursor and complementary to the template nucleic acid;

a fourth reaction chamber comprising non-labeled nucleotide precursors and only a single type of labeled nucleotide precursor being a fourth labeled nucleotide precursor, the forth labeled nucleotide precursor consisting of labeled deoxyuridine-5′

-triphosphate (dUTP), a copy of the template nucleic acid, a synthetic reagent and a primer, the fourth reaction chamber configured to synthesize a fourth labeled nucleic acid strand comprising the fourth labeled nucleotide precursor and complementary to the template nucleic acid;

one or more fluid channels operably coupled to the reaction chambers;

one or more nanopores in each of the reaction chambers, each nanopore being sized to allow the passing of the labeled nucleic acid strands through the nanopore;

a detection unit configured to detect the labeled nucleotide precursors in the labeled nucleic acid strands as the labeled nucleic acid strands pass through the nanopores.

2. The apparatus of claim 1, further comprising a detection unit operably coupled to the nanopores.

3. The apparatus of claim 2, further comprising an information processing and control system operably coupled to the detection unit and configured to record a distance between the labeled nucleotide precursors in the labeled nucleic acid strands as the labeled nucleic acid strands pass through the nanopores.

4. The apparatus of claim 1, wherein the nanopores are between 1 nm and 10 nm in diameter.

5. The apparatus of claim 1, wherein each reaction chamber further includes a surface configured to attach the template nucleic acid.

6. The apparatus of claim 1, wherein the one or more fluid channels include waste port.

7. The apparatus of claim 1, wherein the one or more fluid channels include a template loading port.

8. The apparatus of claim 1, further comprising a molecular dispenser operably coupled to the one or more fluid channels.

9. The apparatus of claim 1, wherein the reaction chambers are made of a transparent material.

10. The apparatus of claim 1, wherein the reaction chambers are made on a single integrated chip.

11. The apparatus of claim 1, wherein a percentage of the labeled nucleotide precursor in each chamber is less than 100% of a total amount of labeled and unlabeled nucleotide precursors of the same type as the labeled nucleotide precursor.

12. The apparatus of claim 11, wherein the percentage of the labeled nucleotide precursors is less than approximately 50% of a total amount of labeled and unlabeled nucleotide precursors of the same type as the labeled nucleotide precursor.

13. The apparatus of claim 11, wherein the percentage of the labeled nucleotide precursor in each reaction chamber is less than approximately 10% of a total amount of labeled and unlabeled nucleotide precursors of the same type as the labeled nucleotide precursor.

14. The apparatus of claim 1, wherein the nanopore is formed from α

-hemolysin.

15. The apparatus of claim 1, wherein each reaction chamber comprises a detector configured to detect a single type of labeled nucleotide precursor.

16. The apparatus of claim 1,

wherein the apparatus is configured to obtain distances between the labeled nucleotide precursors in the labeled nucleic acid strands, and the apparatus is configured to construct distance maps for the labeled nucleotide precursors.

17. The nucleic acid sequencing apparatus of claim 16, wherein the apparatus is further configured to perform overlap analysis to align obtained distances.

18. The nucleic acid sequencing apparatus of claim 17, wherein the apparatus is further configured to perform frequency analysis to determine number of nucleotides around each position.

19. The nucleic acid sequencing apparatus of claim 18, wherein the apparatus is further configured to perform signal analysis to determine distribution of nucleotides around each position.

20. The nucleic acid sequencing apparatus of claim 16, wherein the apparatus is further configured to align distance maps to determine sequence of the template nucleic acid.

21. The apparatus of claim 1, wherein at least one of the nanopores is operably coupled to a light source.